The Impact Of First-Line Tyrosine Kinase Inhibitors (Tkis) On Overall Survival In Patients With Advanced Non-Small Cell Lung Cancer (Nsclc) And Activating Epidermal Growth Factor Receptor (Egfr) Mutations- Meta-Analysis Of Major Randomized ...
Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.1055
https://www.valueinhealthjournal.com/article/S1098-3015(15)03131-9/fulltext
Title :
The Impact Of First-Line Tyrosine Kinase Inhibitors (Tkis) On Overall Survival In Patients With Advanced Non-Small Cell Lung Cancer (Nsclc) And Activating Epidermal Growth Factor Receptor (Egfr) Mutations- Meta-Analysis Of Major Randomized ...
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)03131-9&doi=10.1016/j.jval.2015.09.1055
First page :
A436
Section Title :
Research Podium Presentations - Session 1 and Session 2
Open access? :
No
Section Order :
556